Milrinone lactate and Synthroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Milrinone lactate (milrinone lactate) and Synthroid (levothyroxine sodium). Common drug interactions include anxiety among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Milrinone lactate and Synthroid. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Milrinone lactate?

Milrinone lactate has active ingredients of milrinone lactate. eHealthMe is studying from 580 Milrinone lactate users. Check the latest studies of Milrinone lactate.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,198 Synthroid users. Check the latest studies of Synthroid.



On Jul, 26, 2026

16 people who take Milrinone lactate and Synthroid together, and have interactions are studied.

Milrinone lactate and Synthroid drug interactions.

What are the common drug interactions of Milrinone Lactate and Synthroid, by gender? *:

female:

  1. Anxiety
  2. Depression
  3. Drug maladministration
  4. Emotional distress
  5. Fear
  6. Hypotension (abnormally low blood pressure)
  7. Injury
  8. Lethargy (tiredness)
  9. Multi-organ failure (multisystem organ failure)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Vomiting
  3. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  4. Nausea (feeling of having an urge to vomit)
  5. Pneumonia
  6. Renal failure acute (rapid kidney dysfunction)
  7. Renal failure chronic (long lasting kidney dysfunction)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  10. Subdural haematoma (blood collects between the skull and the surface of the brain)

What are the common drug interactions of Milrinone Lactate and Synthroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cor pulmonale (enlargement of the right ventricle of the heart)
  2. Left ventricular dysfunction
  3. Myocarditis (inflammation of heart muscle myocardium)
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Ejection fraction decreased (systolic heart failure)
  6. Electrocardiogram qt prolonged
  7. Enterococcal sepsis
  8. Respiratory rate increased (excess breathing rate/min)
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  10. Brain natriuretic peptide increased

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Activated partial thromboplastin time prolonged
  2. Cardiac failure congestive
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Haemorrhage (bleeding)
  5. Injection site haemorrhage (bleeding from injection site)
  6. International normalised ratio increased
  7. Oedema (fluid collection in tissue)
  8. Platelet count decreased

60+:

  1. Vomiting
  2. Anaemia (lack of blood)
  3. Nausea (feeling of having an urge to vomit)
  4. Pneumonia
  5. Renal failure acute (rapid kidney dysfunction)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  10. Subdural haematoma (blood collects between the skull and the surface of the brain)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 25.00%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 6.25%
  3. High Blood Pressure: 1 person, 6.25%
  4. High Blood Cholesterol: 1 person, 6.25%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%
  6. Cardiac Failure Congestive: 1 person, 6.25%
  7. Cardiac Disorder: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Milrinone lactate and Synthroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Milrinone lactate and Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Milrinone lactate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Milrinone lactate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synthroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on milrinone lactate and levothyroxine sodium (the active ingredients of Milrinone lactate and Synthroid, respectively), and Milrinone lactate and Synthroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: